OSEBX1 963,65+0,00 %
EQNR371,80+1,03 %
DNB280,60+0,97 %
MOWI205,40+1,18 %
Brent$111,37+0,88 %
Gold$4 579,70−1,08 %
USD/NOK9,2714+0,09 %
EUR/NOK10,8800+0,12 %
SPX7 209,01+0,00 %
NDX27 452,12+0,00 %
LIVE · 09:52 UTC

Petmed Express Inc

PETS · Specialty Retail · United States of America

Profile
TickerPETS
RICPETS.O
ISINUS7163821066
IssuerPetmed Express Inc
SectorConsumer Discretionary
IndustrySpecialty Retail
Sub-industryDrug Retailers
HeadquartersDelray Beach, United States of America
Country of issuerUnited States
Founded1996-01-29
Employees287
Total share float14,868,464
Holders (C/S)75
AuditorRSM US LLP
CEO / managementMs. Leslie C.G. Campbell
Business Description

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

ESG · Risk Indicators
Controversies score100.0
Governance pillar74.1
Social pillar18.4
Insider trading score
Industry Substrate · Retailing (Multiline + Specialty)
Signals to watch
Geopolitical drivers
  • us_china_tariffs_consumer_goods
  • supply_chain_diversification_china_to_alt
  • country_consumer_spending_recovery
  • labor_minimum_wage_country
Industry KPIs
Full Analysis Pending

Detailed financial analysis, valuation snapshot, multi-period history, and AI narrative are pending — generated when this company is included in the next analysis batch. Profile data above is point-in-time as of 2026-04-30.